Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02943473
Title Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai

multiple myeloma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.